TABLE 1.
Clinical summary for the patients whose fungemia cleared on CVC removal or without CVC removal
| Patient no. | Age/sexa | Admission cause | Fungemia durationb | CVC removal (dayb) | Antifungal drug, dose/day (therapy durationb) |
|---|---|---|---|---|---|
| 1 | 66 yr/F | Severe wound infection | 0–6 | Yes (6) | Fluconazole, 400 mg (9–21) |
| 2 | 1.5 mo/F | Low birth weight | 0–11 | Yes (10) | Fluconazole, 6 mg (10–25) |
| 3 | 2 mo/M | Fetal distress | 0–7 | Yes (3) | None |
| 4 | 60 yr/M | Chronic renal failure | 0–2 | Yes (2) | Fluconazole, 100 mg (2–17) |
| 5 | 64 yr/F | Gastric cancer | 0–2 | Yes (2) | None |
| 6 | 1 mo/M | Low birth weight | 0–3 | Yes (3) | Fluconazole, 6 mg (3–17) |
| 7 | 10 days/F | Low birth weight | 0–2 | Yes (3) | Fluconazole, 5 mg (3–19) |
| 8 | 40 yr/M | 3rd degree burn | 0, 4 | No | Fluconazole, 200 mg (4–8) |
| 9 | 61 yr/M | Liver cirrhosis | 0, 6 | No | Amphotericin B, 0.5 mg/kg (6–14) |
a
F, female; M, male.
b
Number of days after the first positive blood culture for each patient.